Ivan Díaz

researcher

Ivan Díaz is …
instance of (P31):
humanQ5

External links are
P496ORCID iD0000-0002-8090-1073
P1053ResearcherIDC-7043-2008
P1153Scopus author ID57191166856

P734family nameDíazQ5255562
DíazQ5255562
DíazQ5255562
P106occupationresearcherQ1650915
P21sex or gendermaleQ6581097

Reverse relations

author (P50)
Q37775727Certainties, doubts and hypotheses in porcine reproductive and respiratory syndrome virus immunobiology.
Q44808944Comparison of different vaccination schedules for sustaining the immune response against porcine reproductive and respiratory syndrome virus.
Q34569610Cytokine profiles and phenotype regulation of antigen presenting cells by genotype-I porcine reproductive and respiratory syndrome virus isolates
Q57207428Development of cell-mediated immunity to porcine circovirus type 2 (PCV2) in caesarean-derived, colostrum-deprived piglets
Q45416506Different European-type vaccines against porcine reproductive and respiratory syndrome virus have different immunological properties and confer different protection to pigs.
Q38441596Distinct functional enrichment of transcriptional signatures in pigs with high and low IFN-gamma responses after vaccination with a porcine reproductive and respiratory syndrome virus (PRRSV).
Q40298624Effects of challenge with a virulent genotype II strain of porcine reproductive and respiratory syndrome virus on piglets vaccinated with an attenuated genotype I strain vaccine.
Q40317891Estimation of the transmission parameters for swine influenza and porcine reproductive and respiratory syndrome viruses in pigs from weaning to slaughter under natural conditions.
Q28748169Granuloma encapsulation is a key factor for containing tuberculosis infection in minipigs
Q40257435Immunization with DNA vaccines containing porcine reproductive and respiratory syndrome virus open reading frames 5, 6, and 7 may be related to the exacerbation of clinical disease after an experimental challenge.
Q39777872Interferon-gamma induction correlates with protection by DNA vaccine expressing E2 glycoprotein against classical swine fever virus infection in domestic pigs.
Q30235375Next-generation sequencing as a tool for the study of Porcine reproductive and respiratory syndrome virus (PRRSV) macro- and micro- molecular epidemiology.
Q112705478Porcine reproductive and respiratory syndrome virus impacts on gut microbiome in a strain virulence-dependent fashion
Q40259551Predicted peptides from non-structural proteins of porcine reproductive and respiratory syndrome virus are able to induce IFN-γ and IL-10.
Q45358655Subclinical porcine circovirus type 2 infection does not modulate the immune response to an Aujeszky's disease virus vaccine.
Q36888431The challenge of PRRS immunology.
Q40296647Transmission of Porcine reproductive and respiratory syndrome virus 1 to and from vaccinated pigs in a one-to-one model.
Q35940931Use of H-Index and Other Bibliometric Indicators to Evaluate Research Productivity Outcome on Swine Diseases
Q90424809Using commercial ELISAs to assess humoral response in sows repeatedly vaccinated with modified live porcine reproductive and respiratory syndrome virus
Q41640514Vaccination with a genotype 1 modified live vaccine against porcine reproductive and respiratory syndrome virus significantly reduces viremia, viral shedding and transmission of the virus in a quasi-natural experimental model